Senior insider sale
President and CEO at VERA THERAPEUTICS, INC. — senior position signals high conviction
$4.53M
115.45K shares
What this filing means
FORDYCE MARSHALL plans to sell 115.45K shares of VERA THERAPEUTICS, INC. valued at approximately $4.53M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/23/2026ACC: 0001950047-26-006433
DirectorOfficer· President and CEO
Since May 2021
115.45K
Shares to sell
$4.53M
Approx. market value
74K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
6/23/2026
74KTotal acquired74K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/23/2026 | Exercise of Stock Options Cash | 74K | — |
| Total | 74K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
18.50K
Market value
$679.7K
5/12/2026
—Completed
Units to sell
22.95K
Market value
$1.01M
4/14/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
74K
Market value
$2.84M
6/23/2026
Total
Units
115.45K
Value
$4.53M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/12/2026 | 18.50K | $679.7K | — | Completed |
4/14/2026 | 22.95K | $1.01M | — | Completed |
| Planned — Approximate Date | ||||
6/23/2026 | 74K | $2.84M | NASDAQ | Planned |
| Total | 115.45K | $4.53M | ||